Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:08 PM ET Form 4
Insider Selling Real Remax Group Inc. REAX

Real Remax Group Insider David L. Liniger Sells $1.01M of Stock

David L. Liniger sold 52,876 shares of Real Remax Group Inc. at $19.12 a share, worth $1.01M in total on Sep 17, 2026. Shares held after the trade: 5,539,905 (-0.9%).

Value
$1.01M
Shares
52,876
Price
$19.12
Holding change
-0.9%
Trade date
Sep 17, 2026
4:07 PM ET 8-K
Leadership Change Bridger Aerospace Group Holdings, Inc. BAER

Bridger Aerospace Group Holdings Leadership Change

Bridger Aerospace Group Holdings, Inc. appointed Rebecca Gerleman as Senior Vice President and Chief Accounting Officer, effective September 18, 2026. Ms. Gerleman previously served as the company's Senior Director of Technical Accounting & Financial Reporting and spent twelve years at Deloitte & Touche LLP prior to joining the firm.

4:07 PM ET 8-K
Leadership Change Turning Point Brands, Inc. TPB

Turning Point Brands Leadership Change

Graham Purdy has resigned as President, CEO, and board member of Turning Point Brands for personal reasons, effective September 30, 2026. The company's Board of Directors has appointed current Executive Chairman David E. Glazek to succeed him as CEO, effective October 1, 2026.

4:06 PM ET 8-K
Investor Presentation PDS Biotechnology Corp PDSB

PDS Biotechnology Investor Presentation

PDS Biotechnology Corporation filed an updated corporate presentation deck as an exhibit to its 8-K. The presentation provides an overview of the company's oncology drug development programs, including PDS0101 and PDS0301, as of September 2026. This filing serves as a strategic update for investors regarding the company's clinical trial pipeline and research collaborations.

4:06 PM ET 8-K
M&A Deal Lantheus Holdings, Inc. LNTH

Lantheus Holdings M&A Deal with Curium US Holdings LLC

Lantheus Holdings provided a regulatory update on its pending merger with Curium US Holdings LLC, noting that Curium voluntarily withdrew and refiled its HSR Act pre-merger notification to provide the FTC with additional time for review. The new 30-day waiting period is set to expire on October 21, 2026, and the parties still expect to close the transaction in the first half of 2027.

Counterparty
Curium US Holdings LLC
4:06 PM ET 8-K
M&A Deal Insight Molecular Diagnostics Inc. IMDX

Insight Molecular Diagnostics M&A Deal with Chronix Biomedical, Inc.

Insight Molecular Diagnostics (iMDx) entered into Amendment No. 2 to its merger agreement with Chronix, modifying the earnout structure related to the CNI Monitor technology. The amendment establishes that equity holders will receive a 10% royalty on sales until a potential sale of the technology occurs, at which point they will receive a final payment of 10% of the gross sale proceeds.

Counterparty
Chronix Biomedical, Inc.
4:06 PM ET 8-K
Loan & Debt Dss, Inc. DSS

Dss $500K Debt Financing with Alset Inc.

DSS, Inc. entered into a securities purchase agreement with related party Alset Inc., receiving a $500,000 loan in exchange for a convertible promissory note and warrants for 8,000,000 shares. The note bears 3% interest and is convertible into common stock at $0.50 per share, while the warrants have an exercise price of $0.55 per share.

Value
$500K
Counterparty
Alset Inc.
Term
5 years
4:05 PM ET 8-K
Loan & Debt CDW Corp CDW

CDW $1.5B Debt Financing with U.S. Bank Trust Company, National Association

CDW Corporation completed a registered offering of $1.5 billion in senior notes across three tranches: $600 million due 2029, $500 million due 2032, and $400 million due 2033. The notes are fully and unconditionally guaranteed by CDW Corporation on an unsecured senior basis and were issued under a base indenture with supplemental indentures.

Value
$1.5B
Counterparty
U.S. Bank Trust Company, National Association
Term
through Sept 2033
4:05 PM ET 8-K
Loan & Debt Techprecision Corp TPCS

Techprecision $4.5M Debt Financing with Beacon Bank & Trust

TechPrecision's subsidiary, Ranor, Inc., entered into a fifteenth amendment to its loan agreement with Beacon Bank & Trust. The amendment extends the maturity date of the company's $4.5 million revolving line of credit from September 15, 2026, to October 16, 2026.

Value
$4.5M
Counterparty
Beacon Bank & Trust
Term
through Oct 16, 2026
4:05 PM ET Form 4
Insider Selling Twist Bioscience Corp TWST

Twist Bioscience CEO Emily M. Leproust Sells $56.3M of Stock

Emily M. Leproust, CEO, sold 356,546 shares of Twist Bioscience Corp at $151.46 to $163.39 a share (average $157.99) in 13 transactions, worth $56.3M in total on Sep 17, 2026. Shares held after the trade: 673,569 (-25.6%).

Value
$56.3M
Shares
356,546
Average price
$157.99
Role
CEO
Holding change
-25.6%
Trade date
Sep 17, 2026
4:05 PM ET Form 4
Insider Selling DoorDash, Inc. DASH

DoorDash Chief Business Officer Keith Yandell Sells $438K of Stock

Keith Yandell, Chief Business Officer, sold 2,184 shares of DoorDash, Inc. at $200.76 a share, worth $438K in total on Sep 17, 2026. Shares held after the trade: 120,688 (-1.8%).

Value
$438K
Shares
2,184
Price
$200.76
Role
Chief Business Officer
Holding change
-1.8%
Trade date
Sep 17, 2026
4:03 PM ET Form 4
Insider Selling Hershey Co HSY

Hershey Insider Hershey Trust Co Trustee in Trust for Milton Hershey School Sells $3.38M of Stock

Hershey Trust Co Trustee in Trust for Milton Hershey School sold 20,000 shares of Hershey Co at $166.77 to $171.34 a share (average $169.08) in 9 transactions, worth $3.38M in total between Sep 17, 2026 and Sep 18, 2026. Shares held after the trade: 766,119 (-0.1%).

Value
$3.38M
Shares
20,000
Average price
$169.08
Holding change
-0.1%
Trade date
Sep 17, 2026 to Sep 18, 2026
4:03 PM ET 8-K
Leadership Change Resources Connection, Inc. RGP

Resources Connection Leadership Change

Resources Connection, Inc. appointed Trisha Jenks as Chief Accounting Officer and principal accounting officer, effective October 3, 2026. Ms. Jenks, who currently serves as the company's SVP and Corporate Controller, succeeds Jennifer Ryu in the principal accounting officer role following Ryu's previously announced resignation. In connection with the appointment, Ms. Jenks' annual base salary will increase to $350,000 with a guaranteed $150,000 target bonus for fiscal 2027.

4:02 PM ET 8-K
Loan & Debt Credit Acceptance Corp CACC

Credit Acceptance $500M Debt Financing with Wells Fargo Bank, National Association

Credit Acceptance Corporation extended two credit facilities with Wells Fargo, including a $500.0 million asset-backed financing (Term ABS 2019-2) and a $500.0 million revolving secured warehouse facility. The amendments extend the revolving periods for both facilities to September 15, 2028, while adjusting interest rates to 5.83% for the Term ABS and SOFR plus 175 basis points for the warehouse facility.

Value
$500M
Counterparty
Wells Fargo Bank, National Association
Term
through Sep 2028
4:02 PM ET Form 4
Insider Selling Sanmina Corp SANM

Sanmina Insider Susan A. Johnson Sells $24.1K of Stock

Susan A. Johnson sold 120 shares of Sanmina Corp at $200.46 a share, worth $24.1K in total on Sep 17, 2026. Shares held after the trade: 10,123 (-1.2%).

Value
$24.1K
Shares
120
Price
$200.46
Holding change
-1.2%
Trade date
Sep 17, 2026
4:01 PM ET 8-K
Capital Raise Electra Therapeutics, Inc. ETRA

Electra Therapeutics Capital Raise of $350M

Electra Therapeutics closed its initial public offering (IPO) of 23,333,334 shares of common stock at a price of $15.00 per share, generating gross proceeds of approximately $350.0 million. In connection with the closing, the company also filed its amended and restated certificate of incorporation and bylaws.

Value
$350M
4:01 PM ET 8-K
Bankruptcy & Restructuring Sangamo Therapeutics, Inc SGMOQ

Sangamo Therapeutics Bankruptcy & Restructuring

Sangamo Therapeutics completed the sale of its ST-920 (Fabry disease gene therapy) assets to PTC Therapeutics for $111 million in cash plus up to $100 million in contingent milestones. The sale was conducted via a court-supervised auction process as part of Sangamo's ongoing Chapter 11 bankruptcy proceedings. Additionally, the company's common stock is being formally delisted from Nasdaq effective September 27, 2026.

Counterparty
PTC Therapeutics, Inc.
4:01 PM ET 8-K/A
Leadership Change WW International, Inc. WW

WW International Leadership Change

WW International, Inc. announced that Stephen J. Bye will officially begin his role as President and Chief Executive Officer on October 1, 2026. Upon his commencement, the Interim Office of the Chief Executive will be dissolved, and Felicia DellaFortuna and Jonathan Volkmann will return to their respective roles as CFO and COO.

Counterparty
Stephen J. Bye
3:35 PM ET 8-K
Financial Results Bloomia Holdings, Inc. TULP

Bloomia Holdings Financial Results

Bloomia Holdings reported fiscal year 2026 revenue of $48.1 million and a net loss of $11.2 million, which included a $13.2 million non-cash impairment charge. The company successfully restructured its balance sheet during the year, reducing total debt by 36% to $21.7 million, while facing operational headwinds from increased bulb costs and production waste.

Term
FY2026

“This fiscal year reminded us that we are, first and foremost, an agricultural business. Unpredictable industry-wide growing difficulties had an outsized negative impact on our margin this year. Despite these external challenges, our underlying business demonstrated significant resilience, in no small part because of the exceptional extra effort and focus the operating team gave in responding to these difficulties and resulting unprecedented waste.”

Mark Jundt, Chairman and Co-Chief Executive Officer

“Additionally, we believe that the short-term financial impact of the waste issue, while significant, will be overshadowed by our big win for the year: thanks to the support and confidence of our stockholders, the Company was able to successfully complete a capital raise that retired over $19 million of debt obligations for approximately $12 million in consideration.”

Mark Jundt, Chairman and Co-Chief Executive Officer
3:30 PM ET 8-K/A
Leadership Change Spruce Power Holding Corp SPRU

Spruce Power Holding Leadership Change

Clara Nagy McBane resigned from the Board of Directors effective September 18, 2026, following the satisfaction of contingencies regarding equity treatment and indemnification. Benjamin Rosenzweig was appointed to the Board to fill the vacancy and will serve on the Compensation Committee, while Shawn Kravetz was appointed to the Audit Committee. In connection with these changes, the Board accelerated the vesting of 93,678 RSUs for Ms. McBane and granted Mr. Rosenzweig $225,000 worth of RSUs.

3:21 PM ET Form 4
Insider Selling Pharvaris N.V. PHVS

Pharvaris Director Elisabeth Bjork Sells $1.99M of Stock

Elisabeth Bjork, Director, sold 52,500 shares of Pharvaris N.V. at $37.89 a share, worth $1.99M in total on Sep 17, 2026. Shares held after the trade: 15,167 (-77.6%).

Value
$1.99M
Shares
52,500
Price
$37.89
Role
Director
Holding change
-77.6%
Trade date
Sep 17, 2026
3:17 PM ET Form 4
Insider Selling Pharvaris N.V. PHVS

Pharvaris Director Robert Glassman Sells $559K of Stock

Robert Glassman, Director, sold 14,493 shares of Pharvaris N.V. at $38.56 a share, worth $559K in total on Sep 17, 2026. Shares held after the trade: 10,500 (-58.0%).

Value
$559K
Shares
14,493
Price
$38.56
Role
Director
Holding change
-58.0%
Trade date
Sep 17, 2026
3:14 PM ET Form 4
Insider Selling Pharvaris N.V. PHVS

Pharvaris Chief Early Development Anne Lesage Sells $765K of Stock

Anne Lesage, Chief Early Development, sold 20,000 shares of Pharvaris N.V. at $38.27 a share, worth $765K in total on Sep 17, 2026. Shares held after the trade: 73,969 (-21.3%).

Value
$765K
Shares
20,000
Price
$38.27
Role
Chief Early Development
Holding change
-21.3%
Trade date
Sep 17, 2026
3:00 PM ET 8-K
Dividend ExchangeRight Income Fund

ExchangeRight Income Fund Dividend

ExchangeRight Income Fund declared a monthly cash dividend of $0.1449 per share for all outstanding common share classes as of August 31, 2026. The filing also provided a routine update on its continuous private placement offering, which has raised $546.75 million to date, and its dividend reinvestment plan.

2:51 PM ET 8-K
Dividend Bancfirst Corp BANF

Bancfirst Dividend

BancFirst Corporation declared a quarterly cash dividend of $0.52 per share on its common stock, payable on October 15, 2026. The company also announced a quarterly interest payment on $26.8 million of its 7.20% Junior Subordinated Debentures to fund a $0.45 per share dividend for BFC Capital Trust II preferred securities.

2:32 PM ET 8-K
Capital Raise Barings Private Credit Corp

Barings Private Credit Capital Raise of $22M

Barings Private Credit Corporation sold approximately 1.1 million unregistered shares of common stock for $22.0 million in a private placement. The company is conducting a continuous private offering for up to $4.5 billion, having raised over $3 billion to date.

Value
$22M
2:26 PM ET 8-K
Leadership Change TriplePoint Private Venture Credit Inc.

TriplePoint Private Venture Credit Leadership Change

Sajal K. Srivastava resigned as President, Chief Investment Officer, and Board member of TriplePoint Private Venture Credit Inc., effective December 31, 2026. Ian Schworer was appointed to succeed him as Chief Investment Officer, while the Board's size will be reduced from five to four members following the departure.

2:23 PM ET 8-K
Leadership Change TriplePoint Venture Growth BDC Corp. TPVG

TriplePoint Venture Growth BDC Leadership Change

Sajal K. Srivastava notified the company of his intention to resign as President, Chief Investment Officer, and Board Director, effective December 31, 2026. In response, the Board appointed Ian Schworer, currently the Chief Credit Officer of TriplePoint Capital, to succeed Srivastava as Chief Investment Officer and reduced the Board size from eight to seven members.

2:16 PM ET 8-K
Executive Compensation Dave & Buster's Entertainment, Inc. PLAY

Dave & Buster's Entertainment Executive Compensation

Dave & Buster's Entertainment, Inc. appointed Amanda Busby as Chief Operations Officer, effective August 11, 2026. Her compensation package includes a $450,000 base salary, a 70% target cash bonus, and a significant equity award consisting of 72,464 RSUs, 74,294 stock options, and 55,741 PSUs. The filing also notes the appointment of Derek Sample as Chief Accounting Officer and several other executive promotions.

Counterparty
Amanda Busby

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.